n(6)-carboxymethyllysine has been researched along with Rheumatoid Arthritis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergaoui, N; Bouzidi, H; Hammami, M; Kerkeni, M; Knani, I; Zrour, S | 1 |
LePage, K; Newkirk, MM; Niwa, T; Rubin, L | 1 |
Bräuer, R; Canet, CC; Drinda, S; Franke, S; Hein, G; Hüttich, C; Petrow, P; Stein, G | 1 |
3 other study(ies) available for n(6)-carboxymethyllysine and Rheumatoid Arthritis
Article | Year |
---|---|
Increased serum concentrations of N
Topics: Adult; Arginine; Arthritis, Rheumatoid; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Severity of Illness Index | 2018 |
Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
Topics: Adult; Antigen-Antibody Complex; Arthritis, Rheumatoid; Autoantibodies; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Glycosylation; Humans; Imidazoles; Immunoblotting; Immunoglobulin G; Immunoglobulin Heavy Chains; Immunoglobulin M; Indians, North American; Lysine; Male; Middle Aged; Nitroblue Tetrazolium; Ontario; Rheumatoid Factor | 1998 |
Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; B-Lymphocytes; Cell Differentiation; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Macrophages; Male; Middle Aged; Oxidative Stress; Synovial Membrane; T-Lymphocytes | 2002 |